3 Under-$10 Biotech Stocks That Could Make You Rich

Low-cap biotech companies are a high-risk but high-reward investment choice. If their clinical trials are successful, that can often mean an explosion in value as investors anticipate a buyout. However, if they fail, that may mean the end of the road for these companies. Here is a list of promising biotechs priced under $10 that could offer a huge return on investment in the coming months.Actinium Pharmaceuticals (ATNM)Source: ShutterstockActinium Pharmaceuticals (NYSEMKT:ATNM) is a biotech working on targe ...